This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
EMRO – Bahrain, Cyprus, Iran, Jordan, Kuwait, Lebanon, Libya, Oman, Qatar, Saudi Arabia, Syria, Tunisia, United Arab Emirates, Egypt, Iraq, Morocco, and Yemen.
- 2.
SEARO – Indonesia, Sri Lanka, Thailand, Malaysia, Phillippines, Brunei, Singapore, Bangladesh, Bhutan, India, Maldives, Nepal, Afganistan, and Pakistan.
References
Atta H.M., 1999. Edwin Smith surgical papyrus: the oldest known surgical treatise. Am Surg 15(12):1190–1192.
Cancer Facts & Figures, 2004. At: http://www.cancer.org/downloads/STT/CAFF_finalPWSecured.pdf
Cancer Facts & Figures, 2006. At: http://www.cancer.org/downloads/STT/CAFF_finalPWSecured.pdf
Cancer Facts and Figures, 2008. At: http://www.cancer.org/downloads/STT/CAFF_finalPWSecured.pdf
CDC, 2006. National Vital Statistics Reports, Vol. 54, Number 13 “Death: Final data for 2003” (by Hoyert D.L., Heron M.P., Murphy S.L., Kung H-C.), at: http://www.cdc.gov/nchs/data/nvsr/nvsr54/nvsr54_13.pdf
CDC/NCHS, 2000a.Vital Statistics of the United States. HIST293. Table: Age-adjusted rates for selected causes by race and sex using year 2000 standard population: death registration states, 1900–32 and United States, 1933–49. At: http://www.cdc.gov/nchs/data/dvs/hist293-1900-49.pdf
CDC/NCHS, 2000b. Vital Statistics System, HIST293. Table: Age-adjusted rates for 60 selected causes by race and sex using year 2000 standard population: United States, 1960–67. At: http://www.cdc.gov/nchs/data/mortab/aadr6067.pdf
CDC/NCHS, 2000c. Vital Statistics System, HIST293. Table: Age-adjusted rates for 72 selected causes by race and sex using year 2000 standard population: United States, 1979–98. At: http://www.cdc.gov/nchs/data/mortab/aadr7998s.pdf
CDC/NCHS, National Vital Statistics System, Mortality, 2000d. HIST293. Table: Age-adjusted death rates for 72 selected causes by race and sex using year 2000 standard population: United States, 1978–98. At: http://www.cdc.gov/nchs/data/mortab/aadr7998s.pdf HIST293. Table: Age-adjusted death rates for 60 selected causes by race and sex using year 2000 standard population: United States, 1960–67. At: http://www.cdc.gov/nchs/data/mortab/aadr6067.pdf HIST293. Table: Age-adjusted death rates for approximately 64 selected causes, by race and sex: United States, 1950–59. At: http://www.cdc.gov/nchs/data/dvs/hist293_1950_59.pdf HIST293. Table: Age-adjusted death rates for selected causes by race and sex using year 2000 standard population: death registration states, 1900–32 and United States, 1933–49. At: http://www.cdc.gov/nchs/data/dvs/hist293_1900_49.pdf
Davis D., 2007. The Secret History of the War on Cancer. New York, NY: Basic Books, 528 pages.
DevCan, 2005. Probability of Developing or Dying of Cancer Software, Version 6.0. Statistical Research Applications Branch, NCI, 2005. http://srab.cancer.gov/devcan American Cancer Society, Surveillance Research, 2006.
Epstein S.S., 2005. Cancer-Gate: How to Win the Losing Cancer War (Policy, Politics, Health and Medicine). Policy, Politics, Health and Medicine Series, Vicente Navarro, Series. Amityville, NY: Baywood Publishing Company. 377 pages.
Extramural Committee to Assess Measures of Progress against Cancer, 1990. Measurement of progress against cancer. J Natl Cancer Inst 82:825–835.
Faquet G.B., 2005. The War on Cancer: An Anatomy of Failure. A Blueprint for the Future. New York: Springer. 227 pages.
Feldman R.P., Goodrich J.T., 1999. The Edwin Smith surgical papyrus. Childs Nerv Syst 15(6–7):281–284.
Ferlay J., Bray F., Pisani P., 2001. Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC CancerBase No.%, Lyon: IARCPress.
Ferlay J., Bray F., Pisani P., Parkin D.M., 2006. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide IARC Cancer Base No. 5, Version 2.0, Lyon: IARC Press, 2004. American Cancer Society, Surveillance Research, 2006.
Fidler I.J., Yano S., Zhang R.D. et al., 2002. The seed and soil hypothesis: vascularization and brain metastasis. Lancet Oncol. 3:53–57.
GLOBOCAN 2002. At: http://www-dep.iarc.fr/globocan/database.htm
Greaves M., 2002. Cancer: The Evolutionary Legacy. New York: Oxford University Press. 288 pages.
Gurunluoglu R., Gurunluoglu A., 2003. Paul of Aegina: landmark in surgical progress. J Sur 27:18–25.
Lee H.S. (ed.), 2000. Dates in Oncology: A Chronological Record of Progress in Oncology over the Last Millenium (Landmarks in Medicine). Lancaster: Parthenon Publishing Group. 124 pages.
Lerner B.H., 2003. The Breast Cancer Wars: Hope, Fear, and the Persuit of a Cure in Twentieth-Century America. New York: Oxford University Press. 416 pages.
Morton L.T., Moore R.J., 1997. A Chronology of Medicine and Related Sciences. Aldershot, England: Scholar Press.
Murray C.J., Evans D.B., Acharya A., 2000. Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ 9:235–251.
Murray C.J.L., Lopez A.D., 1997. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349:1269–1276.
NCI, CDC, State Cancer Profiles. At: http://statecancerprofiles.cancer.gov/historicaltrend/joinpoint.noimage.html
Olson J.S., 2002. Bathsheba’s Breast: Women, Cancer, and History. Baltimore, MD: The John Hopkins University Press. 320 pages.
Pantel K., Cote R.J., Fodsyad O., 1999. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 91:1113–1124.
Parkin D.M., 1999. The global health burden of infection associated cancers. Cancer Surv 33:5–33.
Parkin D.M., Pisani P., Ferlay J., 1999. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80(6):827–841.
Pisani P., Parkin D.M., Bray F., 1999. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83(1):18–29.
Proctor R.N., 1995. Cancer Wars: How Politics Shapes What We Know and Don’t Know About Cancer. New York, NY: Basic Books. 368 pages.
Rosner F., 1998. The Medical Legacy of Moses Maimonides. Hoboken, NJ: KTAV Publishing House Inc.
SEER Cancer Statistics Review 1973–1993. Survival rates, by race, diagnosis year, stage and age. Tables IV-5, V-4, VI-7, VII-4, VIII-4, XI-4, XII-4, XIV-4, XV-7, XVI-4, XIX-4, XX-4, XXI-4, XXII-4, XXIII-4, XXIV-4, XXV-4, XXVI-4. At: http://seer.cancer.gov/csr/1973_1993
SEER Cancer Statistics Review 1975–2004. Survival rates, by race, sex, diagnosis year, stage and age. Table XII-5. Larynx. At: http://seer.cancer.gov/csr/1975_2004/results_merged/sect_12_larynx.pdf
SEER Cancer Statistics Review 1975–2005 (Summary). Summary of changes in cancer mortality, 1950–2005, and 5-year relative survival rates, 1950–2004. Males and females, by primary cancer site. Table I-3. At: http://seer.cancer.gov/csr/1975_2005/results_single/sect_01_table.03.pdf
SEER Cancer Statistics Review 1975–2005. Survival rates, by race, sex, diagnosis year, stage and age, 1996–2004. Tables IV-10, V-5, VII-5, VIII-5, XI-5, XII-5, XIV-5, XV-9, XVI-5, XX-5a, XXI-5, XXII-5, XXIII-5, XXIV-5, XXV-5, XXVI-5, XXVII-5. At: http://seer.cancer.gov/csr/1975_2005/results_merged/topic_survival.pdf
SEER End Results Group, 1960–1973. NCI Surveillance, Epidemiology and End Results Program, 1996.
SEER, Table I-11. Median age of cancer patients at diagnosis, 2000–2003. At: http://seer.cancer.gov/csr/1975_2003/results_single/sect_01_table.11_2pgs.pdf
SEER, Table I-13. Median age of cancer patients at death, 2000–2003. At: http://seer.cancer.gov/crs/1975_2003/results_single/sect_01_table.13_2pgs.pdf
Shibuya K., Mathers C.D., Boschi-Pinto C., Lopez A.D., Murray C.J.L., 2002. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of diseases 2000. BMC Cancer 2:37.
SEEResult Program, 1975–2002. Division of Cancer Control and Population Sciences, Bethesda, MD: NCI, 2005. American Cancer Society Surveillance Research, 2006. At: http://seer.cancer.gov/csr/1975_2003/results_merged/topic_survival.pdf
Tominaga S., Oshima A. (eds.), 2000.http://Cancer mortality and morbidity statistics. Japan and the world – 1999. Japanese Cancer Association, Gann Monograph on Cancer Research No.47. Tokyo: Japan Scientific Societies Press.
U.S. Mortality Public Use Data Tape, 2001. National Center for Health Statistics, Centers for Disease Control and Prevention, 2003.
Udwadia F.E., 2000. Man and Medicine: A History. Oxford: Oxford University Press.
US Mortality Data Files, 2005. Leading causes of death in US. Percent of all causes of death. 1975 vs. 2005. National Center for Health Statistics, Centers for Disease Control and Prevention. At: http://seer.cancer.gov/csr/1975_2005/results_merged/topic_lead_cod.pdf
Vital Statistics of the United States, 1993. United States Cancer Statistics: 2002 Incidence and Mortality, http://www.cdc.gov/cancer/npcr/uscs
Welch H.G., Schwartz L.M., Woloshin S., 2000. Are increasing 5-year survival rates evidence of success against cancer? JAMA 283(22):2975–2978.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Manton, K., Akushevich, I., Kravchenko, J. (2009). Cancer Contra Human: Cohabitation with Casualties?. In: Cancer Mortality and Morbidity Patterns in the U.S. Population. Statistics for Biology and Health. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78193-8_1
Download citation
DOI: https://doi.org/10.1007/978-0-387-78193-8_1
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78192-1
Online ISBN: 978-0-387-78193-8
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)